Rising India, Inc., (OTCPK: RSII), operating as Rising Biosciences, Inc.is a research and development company focusing on oral and topical cannabis and non-cannabis-based pharmaceuticals. Rising Biosciences will also be rolling out its RBS0238 CLINICAL PEPTIDE SERUM (scar serum) in Q2. The company expects their product line will be on sale, available for national distribution, in late April/early May. The serum produces visible results with an effective ingredient base and delivery system.